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Background: Ultrasound gels may contain propylene glycol and glycerol, which are neurotoxic in high
concentrations. If the needle passes through gel during regional anesthesia, gel may be injected near the nerve. It
is unknown if this practice poses a risk for neurotoxicity. Using an animal model, we assessed the histological
changes of perineural propylene glycol on nerves. We then assessed three commonly used sterile gels for evidence
of neurotoxicity.
Methods: Micro-ultrasound guided perineural sciatic nerve injections were performed in mice. Propylene glycol
(PG) 2.5%, 10%, 35%, 70% (v/v) or saline was injected. Nerves were assessed after three days for evidence of
neurotoxicity. Aquasonic® 100 Ultrasound Gel, K-Y® Lubricating Jelly, and PDI® Lubricating Jelly were also studied
against saline controls.
Results: Confluent areas of axonal degeneration and intraneural inflammation occurred in 5 of 9 specimens injected
with 70% PG. At 35%, 2 of 8 specimens showed patchy changes not present at lower concentrations. No degeneration
occurred with Aquasonic® 100 or PDI® Lubricating Jelly. In the K-Y® group, one gel and one saline specimen
demonstrated confluent degenerative changes.
Conclusions: Similar to glycerol, 70% PG may cause confluent areas of axon and myelin degeneration with associated
intraneural inflammation. The concentration of PG present in ultrasound gels is unlikely to cause neurotoxicity.
Aquasonic® 100 and PDI® Lubricating Jelly did not cause neurotoxicity. The results for K-Y® Lubricating Jelly are
inconclusive. There is no evidence that passing the needle through the studied gels during regional anesthesia
procedures is harmful.
Keywords: Ultrasound gel, Neurotoxicity, Regional anesthesia, Ultrasound, Animal models, Nerve injuryBackground
Image quality in ultrasound guided regional anesthesia is
improved by using ultrasound gel as a coupling medium
between the probe and the patient’s skin. Some clinicians
pass the needle through this sterile gel when performing
nerve blocks. It has been demonstrated that regional
anesthesia needles can carry macroscopic quantities of
ultrasound gel into tissues [1]. As a result, ultrasound gel
can potentially be injected around, or into, nerves.* Correspondence: david@belavy.com
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reproduction in any medium, provided the orThe composition of ultrasound and lubricating gels is
often unknown to clinicians but may include the viscous
alcohols glycerol and propylene glycol (PG) [2-6].
Pure glycerol has neurolytic properties but the concen-
tration present in ultrasound gels is probably below that
associated with neurotoxicity [6-8]. Pure PG is also an
effective neurolytic agent and has been proposed as an
alternative to phenol [9]. In the 1950s, a long acting prep-
aration of procaine, called Efocaine, was associated with
tissue sloughing, cellulitis, lumbosacral neuritis and para-
plegia [10-12]. The vehicle contained 78% propylene glycol
and was demonstrated to cause nerve destruction in an
animal model [13]. The lowest concentration of PG associ-
ated with neurotoxicity is unknown.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Ultrasound appearance of the sciatic nerve in
the mouse.
Figure 2 Needle insertion for perineural sciatic nerve injection.
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the potential for neurotoxicity with perineural injection is
unknown. One ultrasound gel (Pharmaceutical Innova-
tions, Newark, NJ) has been studied in a porcine peripheral
nerve model and demonstrated no histological evidence
of neurotoxicity [14]. Another study found that Eko gel
(Eurocamina S.r.l., Salerno, Italy) injected intrathecally
causes meningeal and spinal inflammation [15].
Other sterile gels in common use have not been evalu-
ated. Similarly, the potential for neurotoxicity related to
lower concentrations of propylene glycol has not been
evaluated. This study assesses the concentration-response
relationship between PG and histological nerve damage as
well as the histological effect of perineural injection of
three sterile gels on peripheral nerves.
Methods
The study assessed the histological effects of perineural
injections of propylene glycol and three medical gels in a
mouse model utilizing ultrasound guided microinjection
techniques.
The study was approved by the University of Queensland
Animal Ethics Committee (Anatomical Biosciences) ac-
cording to the principles of the National Health and Med-
ical Research Council’s Australian Code of Practice for the
Care and Use of Animals for Scientific Purposes (7th Edi-
tion 2004) and the Animal Care and Protection Act (2001).
Perineural injection model
Micro-ultrasound guided perineural injection was per-
formed in six to eight week old female CD1 wild-type
mice.
The mice were anesthetized with 5% isoflurane in oxy-
gen in an anesthetizing chamber and maintained with
1.5% isoflurane by nose cone for the duration of the pro-
cedure. The fur over the hind limb was clipped with an
animal clipper. The mouse was turned to the lateral pos-
ition and the hind limb was passed through an orifice in
the bottom of a Petri dish sealed with a silicone mem-
brane. The skin was prepared with 70% ethanol and
allowed to dry. The Petri dish was filled with sterile
phosphate buffered saline (PBS) to act as an ultrasound
conduction medium for imaging, thus avoiding the use
of ultrasound gel.
A Vevo 770 (VisualSonics, Canada) micro-ultrasound
machine with a 25 MHz probe was used to image a
cross section of the sciatic nerve in the proximal hind
limb. The leg was scanned proximally and distally to en-
sure consistent identification of the sciatic nerve. The
sciatic nerve can be identified as a circular structure
running in the fascial layer deep to the biceps femoris
muscle at the mid-thigh (Figure 1).
A 30 G needle was inserted into the thigh using an
in-plane technique and the tip was positioned 0.5 mmaway from the nerve, deep to the biceps femoris muscle
(Figure 2). 0.1 ml of the test substance was injected at a
single point. The injected fluid spread over the nerve
(Figure 3). The preparation was mixed with 12.5 mcl/ml
of 2 micrometre Fluoresbrite® Yellow Green Microspheres
(Polysciences Inc, Warrington PA, USA). These inert, non-
toxic polystyrene and latex microspheres are readily visible
under ultraviolet light. They served as a visual marker of
injection location during the dissection stage [16,17]. The
investigators performing the injections were not blinded to
the injected fluid.
The animals were kept for three days until euthanasia
was performed. Three days was chosen because Schwann
Figure 3 Injectate surrounding the sciatic nerve.
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two days after peripheral nerve injury [18]. After the initial
myelin extrusion, Schwann cell division is maximal at three
days [18]. The sciatic nerve was dissected with care to pre-
vent crushing. The location of the injection around the
sciatic nerve was confirmed by examination under ultra-
violet light demonstrating fluorescence of the micro-
spheres around the sciatic nerve. This area of nerve was
sampled for histological assessment. The nerve was fixed
and processed for histology. Semi-thin Toluidine blue
transverse plastic sections were examined for nerve in-
jury by two blinded neuropathologists. The nerves were
assessed for axonal degeneration, myelin degeneration,
intraneural and perineural inflammation on a qualitative
scale (present, possible or absent).
Propylene glycol concentration-neurotoxicity relationship
The first stage assessed the relationship between the con-
centration of PG injected and histological evidence of




n (%) n (%)
0% n=9 5 (56%) possible in 3 (33%) 0 (0%)
2.5% n=8 8 (100%) 0 (0%)
10% n=8 8 (100%) 0 (0%)
35% n=8 8 (100%) 0 (0%) *
70% n=9 9 (100%) 5 (56%)
PG: Propylene glycol.
* Two specimens showed patchy axonal and myelin degeneration with intraneuralPropylene glycol (Sigma Aldrich, Australia) was diluted
with saline to make five solutions of 2.5%, 10%, 35%, or
70% (v/v) in addition to a saline control. For each concen-
tration, eight animals had 0.1 ml of solution injected
around one sciatic nerve. One additional experiment was
performed with a saline control and 70% propylene glycol
(n=9).
Neurotoxicity assessment of gels
The second stage of the project was to perform perineural
injection of three sterile gels: Aquasonic® 100 Ultrasound
Transmission Gel (Parker Laboratories, USA); K-Y® Lubri-
cating Jelly (Johnson & Johnson, USA); and PDI® Lubricat-
ing Jelly (Professional Disposables International, USA).
Each gel was tested in eight animals (n=24). Each animal
had bilateral perineural injections with saline on one side
and gel on the other. Sample size calculations were not
performed because no data was available to provide an es-
timate of effect size. Descriptive statistics were used.
Results
Propylene glycol
Injections were performed with a saline placebo and vary-
ing concentrations of PG.
In the saline control group (n=9), perineural inflam-
mation was present in five specimens (56%) (Table 1).
One specimen (11%) showed no perineural inflammation
and three (33%) showed subtle changes that were classi-
fied by the pathologists as “possible” perineural inflam-
mation. Perineural inflammation was present with all
injections of PG.
In this model, a single isolated degenerating axon could
be found in many specimens regardless of the injectate (Sa-
line 8 of 9, 2.5% 3 of 8, 10% 4 of 8, 35% 6 of 8, 70% 7 of 9).
As this was present across all concentrations and was not
associated with intraneural inflammation, this pattern was
considered to be normal for the model.
With the injection of 70% PG (n=9), five specimens
(56%) demonstrated confluent areas of axonal degeneration
and intraneural inflammation. At the level of injection, theerative changes on histology
Confluent changes
ration Myelin degeneration Intraneural inflammation
n (%) n (%)
0 (0%) 0 (0%)
0 (0%) 0 (0%)
0 (0%) 0 (0%)
0 (0%) * 2 (25%) *
5 (56%) 6 (66%)
inflammation in smaller fascicles, rather than confluent changes.
Figure 4 Photomicrograph of mouse sciatic nerve (×200)
three days after perineural injection of 70% propylene
glycol. The region to the left is normal. The region on the
right demonstrates a peripheral area of axonal degeneration
under the perineurium.
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fluent changes were restricted to a segment of a fascicle
or several fascicles (Figure 4). The degenerative changes
did not affect the entire nerve. The average depth of
changes from the perineurium was 141 microns (SD 67
microns, range 40 – 205 microns) in the five specimens
affected. This pattern of histological injury was only
seen with the higher concentrations of propylene glycol
(Table 1). Two specimens treated with 35% PG (n=8)
showed patchy axonal and myelin degeneration with intra-
neural inflammation in smaller fascicles, rather than con-
fluent changes. One of these specimens demonstrated
capillary lumen occlusion and endothelial reaction indica-
tive of focal vascular injury.
The analysis of the PG specimens demonstrated that PG
injury is similar to glycerol, producing peripheral confluentTable 2 Histological findings for gels
n
Perineural inflammation Axonal deg
n (%) n (%
Aquasonic® 100
Gel 8 8 (100%) 0 (0
Saline 8 8 (100%) 0 (0
PDI®
Gel 8 8 (100%) 0 (0
Saline 8 7 (82.5%) 0 (0
K-Y®
Gel 8 8 (100%) 1 (13
Saline 8 5 (63%) Possible 2 (25%) 1 (13areas of degeneration. These changes were assessed in the
three gels studied.Gels
The histological findings for the gels are summarized in
Table 2. None of the nerves in the Aquasonic® 100 or
PDI® groups demonstrated confluent areas of axonal de-
generation or intraneural inflammation.
One nerve treated with K-Y® Jelly showed confluent
areas of axon loss affecting several fascicles. The contralat-
eral nerve treated with saline did not show any changes. In
another nerve treated with saline, one fascicle showed a
peripheral wedge of injury with associated intraneural in-
flammation. The contralateral nerve treated with K-Y® did
not show similar changes.Discussion
In this study, we used a murine model of perineural per-
ipheral nerve injection to study the histological effects of
PG and ultrasound gels. PG injection is associated with
confluent areas of axon and myelin degeneration with
intraneural inflammation. These changes were seen in
five of eight specimens treated with 70% PG and, to a lesser
degree, at 35% PG. This adds to existing knowledge that
80% and 100% PG causes complete or partial paralysis with
diffuse degenerative changes of nerves from peripheral to
central portions [9]. We did not find these changes at
lower concentrations.
Perineural administration of 100% glycerol causes neu-
rolysis from the peripheral areas of nerves, but these
changes are not seen at 50% [8]. The histological appear-
ance found with PG is similar to the neurolytic effect of
glycerol [8]. The molecular mechanism of glycerol or pro-
pylene glycol neurolysis is unknown. Diffusion from the
point of injection and direct chemical injury is likely [9].
Another potential cause for a wedge-shaped pattern isConfluent changes
eneration Intraneural inflammation Myelin degeneration
) n (%) n (%)
%) 0 (0%) 0 (0%)
%) 0 (0%) 0 (0%)
%) 0 (0%) 0 (0%)
%) 0 (0%) 0 (0%)
%) 1 (13%) 1 (13%)
%) 1 (13%) 1 (13%)
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The presence of an occluded capillary in one specimen
supports the possibility of vascular injury and ischaemic
neuropathy as a risk factor.
The concentrations of glycerol and PG present in the
studied gels are below that likely to cause neurolysis
after perineural injection [6]. This was confirmed for
Aquasonic® 100 and PDI® lubricating gel, with no specimen
demonstrating histological injury.
The results from K-Y® Jelly are more difficult to inter-
pret. One nerve treated with K-Y® and a nerve treated
with saline from a different animal demonstrated injury.
No other specimen treated with saline showed similar
changes suggesting that another process such as direct
needle trauma or vascular injury may have been involved.
These experiments were performed as a batch on one day
and calls into question the changes found in the one K-Y®
specimen.
Perineural inflammation was seen with all gels and
propylene glycol. This is consistent with a previous study
of ultrasound gel [14]. Pintaric and coworkers found that
intrathecal injection of ultrasound gel in piglets in-
creased protein levels in cerebrospinal fluid and caused
infiltration of inflammatory cells into the meninges and
spinal cord [15]. An inflammatory response occurs after
perineural injection of ultrasound gel but there is no evi-
dence that this is clinically significant.
We observed at least subtle perineural inflammation
in the majority of saline placebo specimens. El-Dawlatly
and coworkers did not observe perineural inflammation
in their placebo group [14]. In their study, the posterior
tibial nerves of dogs were exposed surgically without in-
jection. This difference probably represents a difference
between their canine and our murine models. Qualita-
tively, there was less perineural inflammation in the sa-
line placebo group which is consistent with the findings
of El-Dawlatly. Alternatively, perineural inflammation
may occur from tissue dissection by injected fluid or the
Fluoresbrite® microspheres.
The limitations of this study need to be considered prior
to interpreting the results. This study only assessed histo-
logical injury at one time point (3 days) after perineural in-
jection of gels. Testing at other time points or performing
functional tests for the clinical features of nerve injury may
have increased the sensitivity and clinical applicability. Not
all specimens in the 70% propylene glycol group demon-
strated confluent areas of axonal degeneration. While bio-
logical variability may explain some of the difference,
variation in injection technique cannot be excluded. While
an ultrasound guided injection approximates clinical prac-
tice, a surgical exposure may have yielded more consistent
results. We also did not test intraneural injection which is
likely to pose a greater risk for injury and is clinically rele-
vant [8]. Finally, the pathologists analysing the specimenswere blinded but there is a risk of bias because the investi-
gators performing the injections were not.
In the clinical setting, the volume of gel carried by a nee-
dle will be small and will be diluted by the injected local
anesthetic. Human nerves also have more abundant con-
nective tissue than mouse nerves, [19] and therefore may
have a greater chance of being protected from perineural
alcohols. With these factors in mind, perineurial inflamma-
tion may occur clinically related to injected ultrasound gel,
but it is unlikely to be of clinical significance. We are un-
aware of any clinical cases that have attributed nerve injury
to ultrasound gel.
Conclusions
The absence of histological evidence of neurolysis with
perineural administration of Aquasonic® 100 and PDI®
in this model argues against significant risk with pass-
ing the needle through the studied gels during regional
anesthesia. Removing excess gel from the injection site
may reduce perineural inflammation but this inflammatory
response is of uncertain clinical significance.
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